Pacific Biosciences' HiFi Sequencing technology has been instrumental in a landmark study by the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) that produced the first Arab human pangenome. Published in Nature Communications, the research uncovered millions of previously unidentified genetic variants and 111 million base pairs of DNA absent from existing human genome references. This advancement promotes genomic equity and has implications for disease research. Additionally, HiFi Sequencing demonstrated its high accuracy by detecting mutations as rare as one in 10 million base pairs. The U.S. Food and Drug Administration (FDA) used the HiFi method on the Revio platform to identify ultralow-frequency mutations in TK6 and L5178Y cell lines, revealing genetic variations that other sequencing methods often miss. Complementing this, a Nature research paper detailed structural variation analysis in 1,019 diverse human genomes using long-read sequencing techniques.
HiFi is known for its accuracy, but did you know it can detect mutations as rare as 1 in 10 million base pairs? U.S. FDA authors used it on #Revio to uncover ultralow-frequency mutations in TK6 and L5178Y cells, revealing what other methods often miss. 👇https://t.co/OxWrPqJPs5
HiFi is known for its accuracy, but did you know it can detect mutations as rare as 1 in 10 million base pairs? U.S. FDA authors used it on #Revio to uncover ultralow-frequency mutations in TK6 and L5178Y cells, revealing what other methods often miss.👇 https://t.co/fVIIHafgiB
HiFi is known for its accuracy, but did you know it can detect mutations as rare as 1 in 10 million base pairs? U.S. FDA authors used it on #Revio to uncover ultralow-frequency mutations in TK6 and L5178Y cells, revealing what other methods often miss. https://t.co/fVIIHafgiB